A GUIDE TO UNDERSTANDING & SUPPORT

Posterior cortical atrophy (PCA)

PCA can make reading, navigating and understanding a scene difficult before memory is the main complaint. The syndrome describes a pattern of impairment; identifying the underlying disease is a separate clinical step.

PCA is a progressive brain syndrome that often affects visual and spatial abilities early.

Sources checked 24 Oct 2026Clinical review pendingEditorial sources
Explore the visual example
When a change needs assessment A sudden new field loss, weakness, speech problem or abrupt confusion needs emergency assessment rather than attribution to a progressive diagnosis. Gradually increasing visual-spatial difficulty despite appropriate eye care deserves neurological assessment and review of functional support. [1] [2]
UNDERSTAND THE VISUAL PROBLEM

How the pieces fit together

Original teaching diagram

A simulated blur or blackout would misrepresent higher processing and cognitive changes. [1] [2]

Syndrome, pathology and everyday access

Original educational schematic; it does not diagnose, predict an individual outcome or reproduce a patient’s perception. [1] [2]

Original VisualSim teaching diagram · © VisualSim. Clinical basis in linked sources; not a published study figure. Image provenance.
  1. Clinical pattern

    Identify the particular visual-spatial and cognitive profile.

  2. Assessment

    Distinguish the clinical syndrome from the underlying disease.

  3. Support

    Adapt daily tasks and review changing needs with the person and care partner.

Use this visual explanation alongside the symptom descriptions, assessment information and practical resources below.

01 / THE QUICK EXPLANATION

Understanding Posterior cortical atrophy (PCA)

PCA commonly begins with problems using visual and spatial information: reading, judging space, locating objects or recognizing a complex scene. An ordinary eye examination may not explain the degree of difficulty. Early memory or conversation can seem comparatively preserved, so the problem may be mistaken for an optical issue. [1] [2]

Alzheimer pathology is a common underlying cause, but PCA is not identical to Alzheimer disease in every person. Consensus distinguishes the syndrome, overlapping features and evidence about the underlying pathology, which can matter for counseling and treatment discussions. [2] [3]

02 / WHAT PEOPLE MAY EXPERIENCE

One condition. Different experiences.

03 / WHAT WE KNOW

What is happening—and what remains uncertain

Degenerative changes preferentially involve posterior cortical networks used for visual perception, spatial processing and related functions. The distribution can produce mixtures of simultanagnosia, alexia, recognition problems and visually guided action difficulty. [2] [3]

Syndrome-level testing describes what is happening functionally, while biomarkers and specialist assessment may clarify the disease process. A brain scan alone cannot summarize everyday capability or establish a precise personal timetable. [2] [3]

04 / MAKING DISTINCTIONS

What can look similar?

An eye condition

Cataract, refractive error and other eye disease can coexist. Treatable ocular causes should be assessed without assuming surgery will solve cerebral processing difficulty. [2]

Bálint or Gerstmann features

These describe components that can occur in PCA, not interchangeable names for the entire progressive syndrome. [2] [3]

Other dementias

Lewy body and other pathologies or overlapping syndromes require clinical distinction; a visual symptom alone cannot identify pathology. [2] [3]

Similar-looking symptoms can have different causes. A matching picture cannot establish a diagnosis.

05 / GETTING AN ASSESSMENT

What an assessment may involve

  1. Map visual and cognitive strengthsNeurological and neuropsychological assessment examines spatial, perceptual, reading and other functions, adapting tests for visual limitations. [2]
  2. Assess ocular and structural contributorsEye examination and brain imaging help identify competing explanations and the posterior pattern. [2] [3]
  3. Clarify pathology and daily needsBiomarkers may be relevant to disease-specific decisions, while occupational therapy, communication and mobility assessment address participation now. [2]
06 / CARE AND UNCERTAINTY

What may help—and what is still being studied

Coordinate syndrome and disease care

The treating team considers the underlying pathology, symptoms and any disease-specific options; eligibility cannot be inferred from the PCA label alone. [2]

Use individualized cognitive and visual rehabilitation

Compensatory strategies and environmental adaptations can address goals, but the evidence is more limited than for a universal restorative treatment. [2]

Support the person and care partner

Education, practical planning, emotional support and review of independence needs are part of care, alongside medical follow-up. [2] [4]

07 / DAILY LIFE

What this can mean for daily life

Simplify important visual layouts

Reduce unnecessary items or page complexity where helpful, while preserving meaningful cues and the person’s choices. [2]

Provide alternative information

Spoken, tactile or accessible digital formats can bypass some visual processing demands, depending on other abilities. [2]

Review navigation and household tasks

Occupational and mobility input can assess steps, cooking, dressing and travel; do not assume good chart acuity establishes safe function. [2]

Connect early with support

A PCA-specific group can offer shared experience and practical ideas. Strategies and service access still need individual confirmation. [4] [5]

08 / YOUR NEXT CONVERSATION

Bring a clearer description to your appointment

Choose the questions you want to discuss. These choices stay in this page’s memory.

09 / LOOK CLOSER

Research, with the context left in

Selected studies and guidance, with their populations and limitations. These are curated educational summaries, not a complete systematic review or a formal evidence rating.

2017 · International consensus classification framework.

Consensus classification of posterior cortical atrophy

Separates syndrome-level PCA from overlap syndromes and underlying disease attribution. [3]

Limits and applicability: Classification consensus does not predict individual progression or establish treatment efficacy.

2023 · Clinical review of diagnostic and interdisciplinary management approaches.

Diagnosis and Management of Posterior Cortical Atrophy

Connects assessment, pathology clarification, environmental adaptation and caregiver support. [2]

Limits and applicability: Many nonpharmacological strategies rely on limited studies or expert practice, and disease-specific treatment evidence may not be PCA-specific.

n.d. · Academic clinical and research information.

UCL PCA programme

Explains research priorities and the distinctive visual presentation. [1]

Limits and applicability: A program description is a research/support route, not a clinical trial or proof of benefit.

Questions researchers still need to answer
  • Which interventions improve everyday independence and caregiver outcomes in controlled PCA-specific studies?
  • How should disease-modifying therapy outcomes be assessed when visual-spatial impairment predominates?
10 / KEEP LEARNING

Trusted places to go next

Selected clinical references, research, practical support and ways to connect. Official pages checked 24 October 2026; each entry explains its scope and region.

Charity & support · UK-led support network; online information and some remote activities; check individual eligibility.

Rare Dementia Support

PCA-specific support information, meetings and connection routes.

Connections listed by the organization.

Charity & support · UK charity; public education online internationally.

Alzheimer’s Research UK — PCA support

Practical signposting to PCA support and family experience.

Research · Public online education; local clinical services have their own access requirements.

UCL — PCA programme

Academic research and clinical background on the syndrome.

Research · Public online education; local clinical services have their own access requirements.

PCA diagnosis and management review

Open specialist discussion of diagnosis, care and evidence limitations.

11 / COMMON QUESTIONS

Questions you may still have

Can memory be relatively good early on?

Yes. Early visual and spatial problems can predominate despite comparatively preserved memory or conversation. [2] [3]

Is every case Alzheimer disease?

No. Alzheimer pathology is common, but syndrome and underlying pathology are separate diagnostic levels. [2] [3]

Will changing glasses fix the whole problem?

Correcting eye problems remains worthwhile, but posterior processing impairment is not simply optical blur. [2]

Can a simulator reproduce PCA?

No single filter can reproduce the changing combination of perception, attention, reading, action and cognition. Task explanations are more honest. [2]

12 / TRANSPARENCY

Sources, image credits and review status

Compiled by VisualSim from clinical references and published research. Sources checked 24 October 2026. Independent clinical review has not been recorded; no named clinical reviewer or clinical validation is claimed. Research evidence and its limitations are linked below.

  1. UCL — Posterior cortical atrophy programme (n.d.; institution).

    Official clinical source checked for this topic; source checking is not clinical review.

    Checked 2026-10-24 · Public page checked
  2. Diagnosis and Management of Posterior Cortical Atrophy (2023; review).

    Official clinical source checked for this topic; source checking is not clinical review.

    Checked 2026-10-24 · Full text checked
  3. Crutch et al. — Consensus classification of posterior cortical atrophy (2017; guideline).

    Official indexed consensus sections and academic author-PDF route checked; no image reuse.

    Checked 2026-10-24 · Abstract/indexed material checked; complete full-text review not claimed
  4. Rare Dementia Support (n.d.; institution).

    Official indexed support pages checked; direct home fetch sometimes timed out.

    Checked 2026-10-24 · Public page checked
  5. Alzheimer’s Research UK — PCA support (n.d.; institution).

    Official clinical source checked for this topic; source checking is not clinical review.

    Checked 2026-10-24 · Public page checked

The simulator helps people communicate an experience. It cannot diagnose a condition, measure a visual field, or establish that someone is safe to drive.

Enlarged figure